These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7937967)

  • 41. Thermodynamics of transient conformations in the folding pathway of barnase: reorganization of the folding intermediate at low pH.
    Oliveberg M; Fersht AR
    Biochemistry; 1996 Feb; 35(8):2738-49. PubMed ID: 8611580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the protein folding transition state by mutation: Large scale (un)folding rate accelerations without altering native stability.
    Campos LA; Muñoz V
    Protein Sci; 2024 Jul; 33(7):e5031. PubMed ID: 38864692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein fragments as models for events in protein folding pathways: protein engineering analysis of the association of two complementary fragments of the barley chymotrypsin inhibitor 2 (CI-2).
    Ruiz-Sanz J; de Prat Gay G; Otzen DE; Fersht AR
    Biochemistry; 1995 Feb; 34(5):1695-701. PubMed ID: 7849029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cooperative folding of the isolated alpha-helical domain of hen egg-white lysozyme.
    Bai P; Peng Z
    J Mol Biol; 2001 Nov; 314(2):321-9. PubMed ID: 11718563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The complete folding pathway of a protein from nanoseconds to microseconds.
    Mayor U; Guydosh NR; Johnson CM; Grossmann JG; Sato S; Jas GS; Freund SM; Alonso DO; Daggett V; Fersht AR
    Nature; 2003 Feb; 421(6925):863-7. PubMed ID: 12594518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conserved residues and the mechanism of protein folding.
    Shakhnovich E; Abkevich V; Ptitsyn O
    Nature; 1996 Jan; 379(6560):96-8. PubMed ID: 8538750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The slow folding reaction of barstar: the core tryptophan region attains tight packing before substantial secondary and tertiary structure formation and final compaction of the polypeptide chain.
    Sridevi K; Juneja J; Bhuyan AK; Krishnamoorthy G; Udgaonkar JB
    J Mol Biol; 2000 Sep; 302(2):479-95. PubMed ID: 10970747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure.
    Matouschek A; Serrano L; Fersht AR
    J Mol Biol; 1992 Apr; 224(3):819-35. PubMed ID: 1569559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; de Prat Gay G; Fersht AR
    J Mol Biol; 1997 Oct; 273(1):317-29. PubMed ID: 9367764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local breathing and global unfolding in hydrogen exchange of barnase and its relationship to protein folding pathways.
    Clarke J; Hounslow AM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9837-41. PubMed ID: 8234322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of two buried salt bridges in the stability and folding pathway of barnase.
    Tissot AC; Vuilleumier S; Fersht AR
    Biochemistry; 1996 May; 35(21):6786-94. PubMed ID: 8639630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-time NMR studies on folding of mutants of barnase and chymotrypsin inhibitor 2.
    Killick TR; Freund SM; Fersht AR
    FEBS Lett; 1998 Feb; 423(1):110-2. PubMed ID: 9506851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineering stabilising beta-sheet interactions into a conformationally flexible region of the folding transition state of ubiquitin.
    Bofill R; Searle MS
    J Mol Biol; 2005 Oct; 353(2):373-84. PubMed ID: 16169558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneous packing in the folding/unfolding intermediate state of bitter gourd trypsin inhibitor.
    Takahashi D; Matsumoto S; Nishimoto E; Otosu T; Yamashita S
    Biosci Biotechnol Biochem; 2008 Jun; 72(6):1498-505. PubMed ID: 18540100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of Secondary-Structure Folding on the Mutually Exclusive Folding Process of GL5/I27 Protein: Evidence from Molecular Dynamics Simulations.
    Wang Q; Wang Y; Chen G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of two-state to multi-state folding kinetics on fusion of two protein foldons.
    Inaba K; Kobayashi N; Fersht AR
    J Mol Biol; 2000 Sep; 302(1):219-33. PubMed ID: 10964571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative all-atomic study of unfolding pathways for proteins chymotrypsin inhibitor 2 and barnase.
    Sheng Y; Wang W
    Phys Rev E Stat Nonlin Soft Matter Phys; 2006 Feb; 73(2 Pt 1):021915. PubMed ID: 16605370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The "first in-last out" hypothesis on protein folding revisited.
    Pintar A; Pongor S
    Proteins; 2005 Sep; 60(4):584-90. PubMed ID: 16021637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-dependent stability and folding kinetics of a protein with an unusual alpha-beta topology: the C-terminal domain of the ribosomal protein L9.
    Sato S; Raleigh DP
    J Mol Biol; 2002 Apr; 318(2):571-82. PubMed ID: 12051860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.